Investor Relations Home

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports Fourth Quarter 2017 Financial Results
	2017 Form 10K
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

10/02/08

Summary Toggle Masimo Announces $1 Million Performance Guarantee Launches 'Fact vs. Fiction' website. IRVINE, Calif., Oct.
09/15/08

Summary Toggle Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin Adhesive Sensors IRVINE, Calif., Sept.
09/10/08

Summary Toggle Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices IRVINE, Calif., Sept.
08/27/08

Summary Toggle Masimo Announces Dismissal of Litigation Brought by Shaklee and NIR Diagnostics IRVINE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced that it has settled pending litigation brought by Shaklee Corporation and NIR Diagnostics, Inc.
08/26/08

Summary Toggle Masimo to Present at Thomas Weisel Partners Healthcare Conference 2008 IRVINE, Calif., Aug.
08/06/08

Summary Toggle Masimo Corporation (MASI) CEO, Chairman and Founder to Ring the NASDAQ Stock Market Opening Bell What: Joe Kiani, CEO, Chairman and Founder of Masimo Corporation (MASI), will preside over the opening bell. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Thursday, August 7, 2008 at 9:30 a.m. ET The opening bell is available from 9:20 a.m. to 9:35 a.m.
08/04/08

Summary Toggle Masimo Reports Second Quarter 2008 Financial Results Record results mark 20th consecutive quarter of revenue growth Q2 2008 Highlights: * Product revenues increased 30% to a record $61.9 million * Direct (Non-OEM) Business revenues increased by 46% * Shipped 29,000 new pulse oximeters and Pulse CO-Oximeters IRVINE, Calif., Aug.
07/31/08

Summary Toggle Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology Masimo provides Aurora with technology and sensor standardization across its facilities - creating efficiencies and cost savings IRVINE, Calif., July 31 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse Oximetry, announced that Aur
07/18/08

Summary Toggle Masimo to Report Second Quarter 2008 Financial Results on August 4, 2008 Conference call and webcast to begin after markets close at 2:00 p.m. PT (5:00 p.m.
07/10/08

Summary Toggle New Study Demonstrates Masimo's Noninvasive PVI(TM) Measurement Can Predict Fluid Responsiveness During Surgery Publication in 'British Journal of Anaesthesia' reveals PVI has similar or better accuracy compared to multiple invasive methods IRVINE, Calif., July 10 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, tod

Receive E-mail Alerts

To request a copy of the Annual Report, click here .

Investor Relations Home

Q1 2018 Masimo Corporation Earnings Conference Call

Masimo at the Barclays Global Healthcare Conference

Stock Quote

Online Investor Kit

Supplemental Financial Information

Corporate Profile

Upcoming Events

Recent News